ABVC
ABVC BIOPHARMA, INC.
Key Financials
Net Income
$-7908554
↓ 61.3%
Operating Income
$-7151259
↓ 52.0%
Gross Profit
$508826
0.0%
Revenue
$509589
0.0%
Total Assets
$21.1M
↑ 179.3%
EPS (Diluted)
$-0.39
↑ 7.1%
Total Liabilities
$7.8M
↑ 13.9%
Shareholders' Equity
$11.1M
↑ 806.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| DEF 14A | 9/29/2026 | View on SEC |
| PRER14A | 9/11/2026 | View on SEC |
| 8-K | 8/27/2026 | View on SEC |
| PRER14A | 8/25/2026 | View on SEC |
| 424B4 | 8/17/2026 | View on SEC |
| 424B4 | 8/17/2026 | View on SEC |
| 424B4 | 8/17/2026 | View on SEC |
| 424B4 | 8/17/2026 | View on SEC |
| PRER14A | 8/12/2026 | View on SEC |
| 10-Q | 8/12/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ABVC |
| Company Name | ABVC BIOPHARMA, INC. |
| CIK | 1173313 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 510-668-0881 |